CD4 and glioma: The results showed that triptolide can reverse the inhibitory effect on CD4+ T cells in the glioma immunosuppressive microenvironment, which was consistent with the Flies group’s investigation that the inhibition of CD4+ T cells mainly accounts for the tumor immunosuppressive microenvironment [84].